The exact prevalence and incidence of achlorhydria are not known. Gastric corpus atrophy, defined by decreases in pepsinogen I and pepsinogen I/II ratio, is present in 10% to 15% of older people.[20]Weck MN, Stegmaier C, Rothenbacher D, et al. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007 Sep 15;26(6):879-87.
http://www.ncbi.nlm.nih.gov/pubmed/17767472?tool=bestpractice.com
[21]Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):651-60.
http://www.ncbi.nlm.nih.gov/pubmed/18685464?tool=bestpractice.com
[22]Webb PM, Hengels KJ, Moller H, et al. The epidemiology of lower serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology. 1994 Nov;107(5):1335-44.
http://www.ncbi.nlm.nih.gov/pubmed/7926498?tool=bestpractice.com
[23]Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol. 2009 Feb;24(2):193-201.
http://www.ncbi.nlm.nih.gov/pubmed/19215332?tool=bestpractice.com
[24]Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996 May 27;156(10):1097-100.
http://www.ncbi.nlm.nih.gov/pubmed/8638997?tool=bestpractice.com
Gastric corpus atrophy is reported to be present in 16% of dyspeptic patients.[25]Lombardo L, Leto R, Molinaro G, et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med. 2010 Sep;48(9):1327-32.
http://www.ncbi.nlm.nih.gov/pubmed/20604730?tool=bestpractice.com
Incidence rates of gastric corpus atrophy vary widely, ranging from 0% to 11% per year, with substantially higher rates observed in Helicobacter pylori-positive compared with H pylori-negative people.[26]Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995 Dec 6;87(23):1777-80.
http://www.ncbi.nlm.nih.gov/pubmed/7473834?tool=bestpractice.com
[27]Adamu MA, Weck MN, Gao L, et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010 Jul;25(7):439-48.
http://www.ncbi.nlm.nih.gov/pubmed/20585973?tool=bestpractice.com
In a population-based study from Sweden, the prevalence of atrophic corpus gastritis in participants aged 55 to 64 years old decreased from 124 per 1000 to 49 per 1000 individuals between 1990 and 2009, whereas the prevalence unexpectedly increased from 22 per 1000 to 64 per 1000 among participants aged 35 to 44 years old.[28]Song H, Held M, Sandin S, et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in northern Sweden between 1990 and 2009. Clin Gastroenterol Hepatol. 2015 Sep;13(9):1592-600;e1.
http://www.ncbi.nlm.nih.gov/pubmed/25857683?tool=bestpractice.com
Gastric corpus atrophy is associated with intestinal metaplasia and carries a 2- to 3-fold increased risk for gastric adenocarcinoma.[24]Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996 May 27;156(10):1097-100.
http://www.ncbi.nlm.nih.gov/pubmed/8638997?tool=bestpractice.com
Pernicious anaemia, a common cause of cobalamin deficiency, caused by auto-antibodies directed against intrinsic factor and/or parietal cells, affects >2% of people over the age of 60 years.[24]Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996 May 27;156(10):1097-100.
http://www.ncbi.nlm.nih.gov/pubmed/8638997?tool=bestpractice.com
In a population study of 9684 German people aged 50 to 74 years, parietal cell antibodies, detected by enzyme-linked immunosorbent assay (ELISA), were present in 20% of subjects.[29]Zhang Y, Weck MN, Schöttker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):821-6.
http://cebp.aacrjournals.org/content/22/5/821.long
http://www.ncbi.nlm.nih.gov/pubmed/23456556?tool=bestpractice.com
The parietal cell antibodies are directed against hydrogen-potassium-stimulated adenosine triphosphatase (H+/K+ ATPase), the proton pump of the parietal cell.[30]Toh BH, Alderuccio F. Pernicious anemia. Autoimmunity. 2004 Jun;37(4):357-61.
http://www.ncbi.nlm.nih.gov/pubmed/15518059?tool=bestpractice.com
[31]Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol. 1989 Oct;42(10):1092-5.
http://jcp.bmj.com/content/42/10/1092.long
http://www.ncbi.nlm.nih.gov/pubmed/2584410?tool=bestpractice.com